Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Autoimmune Disorders

  Free Subscription

Articles published in Diabet Med

Retrieve available abstracts of 297 articles:
HTML format

Single Articles

    March 2024
  1. MOSER O, Pemberton JS
    Rethinking the safety and efficacy assessment of (Hybrid) Closed Loop systems: Should we promote the need for a minimum of exercise data within the regulatory approval?
    Diabet Med. 2024;41:e15305.

    February 2024
  2. STANLEY AK, Duncan K, Anderson D, Irvine L, et al
    Insulin independence following islet transplantation improves long-term metabolic outcomes.
    Diabet Med. 2024;41:e15257.
    PubMed     Abstract available

    January 2024
  3. ZHOU Y, Sardana D, Kuroko S, Haszard JJ, et al
    Comparing the glycaemic outcomes between real-time continuous glucose monitoring (rt-CGM) and intermittently scanned continuous glucose monitoring (isCGM) among adults and children with type 1 diabetes: A systematic review and meta-analysis of randomi
    Diabet Med. 2024 Jan 10:e15280. doi: 10.1111/dme.15280.
    PubMed     Abstract available

    December 2023
  4. WIBAEK R, Ibfelt EH, Andersen GS, Hulman A, et al
    Heterogeneity in glycaemic control in children and adolescents with type 1 diabetes: A latent class trajectory analysis of Danish nationwide data.
    Diabet Med. 2023 Dec 29:e15275. doi: 10.1111/dme.15275.
    PubMed     Abstract available

  5. HONG TW, Caxaria S, Daniels Gatward LF, Hussain S, et al
    Mesenchymal stromal cell secretory molecules improve the functional survival of human islets.
    Diabet Med. 2023;40:e15227.
    PubMed     Abstract available

    November 2023
  6. GRAMMES J, Schmid S, Bozkurt L, Heinemann L, et al
    Continuous glucose monitoring in older adults with diabetes: Data from the diabetes prospective follow-up (DPV) registry.
    Diabet Med. 2023 Nov 27:e15261. doi: 10.1111/dme.15261.
    PubMed     Abstract available

  7. STIMSON RH, Dover AR, Strachan MWJ, Wright RJ, et al
    Changes in continuous glucose monitoring metrics and predictors of improvement 12 months after conversion from Freestyle Libre to Freestyle Libre 2.
    Diabet Med. 2023;40:e15130.
    PubMed     Abstract available

  8. XIE S, Li M, Chen X, Guo W, et al
    Health State Utility Values for Children and Adolescents with Type 1 Diabetes: A Systematic Review and Meta-analysis.
    Diabet Med. 2023 Nov 1:e15251. doi: 10.1111/dme.15251.
    PubMed     Abstract available

    October 2023
  9. LEELARATHNA L, Sutton CJ, Evans ML, Neupane S, et al
    Intermittently scanned continuous glucose monitoring in adults with type 1 diabetes: A subgroup analysis from the FLASH-UK study.
    Diabet Med. 2023 Oct 28:e15249. doi: 10.1111/dme.15249.
    PubMed     Abstract available

  10. RENAUD-CHAREST O, Mok E, Frei J, Brunet ML, et al
    Diabetes duration, perceived comfort with self-management and glycaemic control in adolescents with type 1 diabetes: A cross-sectional study.
    Diabet Med. 2023 Oct 14:e15237. doi: 10.1111/dme.15237.
    PubMed     Abstract available

  11. FELEKE BE, Sacre J, Tomic D, Huynh Q, et al
    Hospital admissions among people with diabetes: a systematic review.
    Diabet Med. 2023 Oct 9:e15236. doi: 10.1111/dme.15236.
    PubMed     Abstract available

  12. NALLY LM, Sherr JL, Tichy E, Weyman K, et al
    Impact of school-supervised ultra-long-acting basal insulin injections on ketosis in youth with T1D and elevated haemoglobin A1c: A pilot study.
    Diabet Med. 2023;40:e15123.
    PubMed     Abstract available

    September 2023
  13. ELLIOTT RA, Rogers G, Evans ML, Neupane S, et al
    Estimating the cost effectiveness of intermittently scanned continuous glucose monitoring in adults with type 1 diabetes in England.
    Diabet Med. 2023 Sep 26:e15232. doi: 10.1111/dme.15232.
    PubMed     Abstract available

  14. SOHOLM U, Holmes-Truscott E, Broadley M, Amiel SA, et al
    Hypoglycaemia symptom frequency, severity, burden, and utility among adults with type 1 diabetes and impaired awareness of hypoglycaemia: Baseline and 24 weeks findings from the HypoCOMPaSS study.
    Diabet Med. 2023 Sep 25:e15231. doi: 10.1111/dme.15231.
    PubMed     Abstract available

  15. LEETE P
    Type 1 diabetes in the Pancreas: A histological perspective.
    Diabet Med. 2023 Sep 21:e15228. doi: 10.1111/dme.15228.
    PubMed     Abstract available

  16. BEROT A, Morsa M, De Andrade V, Gagnayre R, et al
    Lack of consideration of socioeconomic factors in transition program of adolescents with type 1 diabetes: a systematic review.
    Diabet Med. 2023 Sep 15:e15225. doi: 10.1111/dme.15225.
    PubMed     Abstract available

  17. TANAKA JHZ, Del Valle A, Bernabe-Ortiz A, Miranda JJ, et al
    Outcomes measured in studies assessing health systems interventions for type 1 diabetes management: A scoping review.
    Diabet Med. 2023 Sep 8:e15223. doi: 10.1111/dme.15223.
    PubMed     Abstract available

  18. KELLY RC, Holt RIG, Desborough L, Majidi S, et al
    The Psychosocial Burdens of Living with Diabetes.
    Diabet Med. 2023 Sep 3:e15219. doi: 10.1111/dme.15219.
    PubMed     Abstract available

  19. VAN DEN HEUVEL T, Castaneda J, Arrieta A, Cohen O, et al
    Letter to the editor: Nuances from the manufacturer regarding the ABCD-DTN best practice guide on the use of MiniMed 780G advanced hybrid closed loop system.
    Diabet Med. 2023;40:e15171.

  20. SCHNEIDER-UTAKA AK, Hanes S, Boughton CK, Hartnell S, et al
    Patient-reported outcomes for older adults on CamAPS FX closed loop system.
    Diabet Med. 2023;40:e15126.
    PubMed     Abstract available

  21. ROOS J, Schurch D, Frei A, Lagger S, et al
    Time requirements for perioperative glucose management using fully closed-loop versus standard insulin therapy: A proof-of-concept time-motion study.
    Diabet Med. 2023;40:e15116.
    PubMed     Abstract available

    August 2023
  22. TOMIC D, Craig ME, Magliano DJ, Shaw JE, et al
    Reasons for hospitalisation in youth with type 1 diabetes, 2010-2019.
    Diabet Med. 2023 Aug 31:e15218. doi: 10.1111/dme.15218.

  23. LEE WK, Ko MSM, Ang LC, Zhu L, et al
    A Real-Life Comparison of Hypoglycaemia Symptomatology between Insulin-treated Type 2 Diabetes Participants with and without Impaired Awareness of Hypoglycaemia (IAH).
    Diabet Med. 2023 Aug 28:e15215. doi: 10.1111/dme.15215.
    PubMed     Abstract available

  24. TANG TS, Yip AKW, Klein G, Moore L, et al
    Training peers to deliver mental health support to adults with Type 1 diabetes using the REACHOUT Mobile App.
    Diabet Med. 2023 Aug 27:e15210. doi: 10.1111/dme.15210.
    PubMed     Abstract available

  25. AMER BE, Yaqout YE, Abozaid AM, Afifi E, et al
    Does fully closed-loop automated insulin delivery improve glycaemic control in patients with type 2 diabetes? A meta-analysis of randomized controlled trials.
    Diabet Med. 2023 Aug 11:e15196. doi: 10.1111/dme.15196.
    PubMed     Abstract available

  26. HENDRIECKX C, Husin HM, Russell-Green S, Halliday JA, et al
    The Diabetes Management Experiences Questionnaire: Psychometric validation among adults with type 1 diabetes.
    Diabet Med. 2023 Aug 10:e15195. doi: 10.1111/dme.15195.
    PubMed     Abstract available

    July 2023
    Is socioeconomic status associated with risk of childhood type 1 diabetes? Literature review.
    Diabet Med. 2023 Jul 25:e15182. doi: 10.1111/dme.15182.
    PubMed     Abstract available

  28. STENOV V, Due-Christensen M, Cleal BR, Tapager IW, et al
    Significant reduction in diabetes-distress and improvements in psychosocial outcomes: A pilot-test of an intervention to reduce diabetes distress in adults with type 1 diabetes and moderate to severe diabetes distress (REDUCE).
    Diabet Med. 2023 Jul 20:e15187. doi: 10.1111/dme.15187.
    PubMed     Abstract available

  29. SONG SH, Frier BM
    Does sensor technology lower the prevalence of impaired hypoglycaemia awareness in type 1 diabetes?
    Diabet Med. 2023 Jul 20:e15185. doi: 10.1111/dme.15185.

  30. HELMINK MAG, Hageman SHJ, Visseren FLJ, de Ranitz-Greven WL, et al
    Variability in benefit from intensive insulin therapy on cardiovascular events in individuals with type 1 diabetes: a post-hoc analysis of the DCCT/EDIC study.
    Diabet Med. 2023 Jul 20:e15183. doi: 10.1111/dme.15183.
    PubMed     Abstract available

  31. JAMES S, Donaghue KC, Perry L, Lowe J, et al
    Low-density lipoprotein cholesterol in adolescents and young adults with type 1 diabetes: Data from the Australasian Diabetes data network (Addn) registry.
    Diabet Med. 2023 Jul 19:e15184. doi: 10.1111/dme.15184.
    PubMed     Abstract available

  32. OZORAN H, Matheou M, Dyson P, Karpe F, et al
    Type 1 diabetes and low carbohydrate diets - defining the degree of nutritional ketosis.
    Diabet Med. 2023 Jul 16:e15178. doi: 10.1111/dme.15178.

  33. TITORIA R, Fung A, Tang TS, Amed S, et al
    Systematic Review Of Technology Mediated Peer Support Interventions In Pediatric Type 1 Diabetes Care.
    Diabet Med. 2023 Jul 10:e15172. doi: 10.1111/dme.15172.
    PubMed     Abstract available

  34. HASHIM R, Forde R, Ausili D, Forbes A, et al
    Prevalence and associated factors of sexual dysfunction in premenopausal women with type 1 diabetes: A systematic review and meta-analysis.
    Diabet Med. 2023 Jul 5:e15173. doi: 10.1111/dme.15173.
    PubMed     Abstract available

  35. SEHGAL S, Boucsein A, Styles S, Palmer O, et al
    Do-it-yourself continuous glucose monitoring (DIY-CGM) in people aged 16 to 69 years with type 1 diabetes: a qualitative study.
    Diabet Med. 2023 Jul 2:e15168. doi: 10.1111/dme.15168.
    PubMed     Abstract available

  36. UDUKU C, Pendolino V, Jugnee N, Oliver N, et al
    Real-time continuous glucose monitoring immediately after severe hypoglycaemia requiring emergency medical services: A randomised controlled trial.
    Diabet Med. 2023;40:e15100.
    PubMed     Abstract available

    June 2023
  37. ALI N, El Hamdaoui S, Nefs G, Walburgh Schmidt JWJ, et al
    High diabetes-specific distress among adults with type 1 diabetes and impaired awareness of hypoglycaemia despite widespread use of sensor technology.
    Diabet Med. 2023 Jun 22:e15167. doi: 10.1111/dme.15167.
    PubMed     Abstract available

  38. PROPPER-LEWINSOHN T, Gillon-Keren M, Shalitin S, Elran-Barak R, et al
    Disordered eating behaviours in adolescents with type 1 diabetes can be influenced by their weight at diagnosis and rapid weight gain subsequently.
    Diabet Med. 2023 Jun 14:e15166. doi: 10.1111/dme.15166.
    PubMed     Abstract available

  39. SARTEAU AC, Muthukkumar R, Smith C, Busby-Whitehead J, et al
    Supporting the 'lived expertise' of older adults with type 1 diabetes: an applied focus group analysis to characterize barriers, facilitators, and strategies for self-management in a growing and understudied population.
    Diabet Med. 2023 Jun 6:e15156. doi: 10.1111/dme.15156.
    PubMed     Abstract available

  40. SOUFI A, Mok E, Henderson M, Dasgupta K, et al
    Association of Stigma, Diabetes Distress and Self-efficacy with Quality of Life in Adolescents with Type 1 Diabetes Preparing to Transition to Adult Care.
    Diabet Med. 2023 Jun 3:e15159. doi: 10.1111/dme.15159.
    PubMed     Abstract available

  41. ACCIAROLI G, Parkin CG, Thomas R, Layne J, et al
    G6 continuous glucose monitoring system feature use and its associations with glycaemia in Europe.
    Diabet Med. 2023;40:e15093.
    PubMed     Abstract available

  42. BERNABE-ORTIZ A, Carrillo-Larco RM, Safary E, Vetter B, et al
    Use of continuous glucose monitors in low- and middle-income countries: A scoping review.
    Diabet Med. 2023;40:e15089.
    PubMed     Abstract available

  43. WANG XS, Dunlop AD, McKeen JA, Feig DS, et al
    Real-world use of Control-IQ technology automated insulin delivery in pregnancy: A case series with qualitative interviews.
    Diabet Med. 2023;40:e15086.
    PubMed     Abstract available

    May 2023
  44. WAGNER S, Norgaard K, Willaing I, Olesen K, et al
    The impact of upper extremity impairments on work and everyday life of people with type 1 diabetes - a nationwide controlled study.
    Diabet Med. 2023 May 31:e15158. doi: 10.1111/dme.15158.
    PubMed     Abstract available

  45. TORABI F, Vadakekolathu J, Wyatt R, Leete P, et al
    Differential expression of genes controlling lymphocyte differentiation and migration in two distinct endotypes of type 1 diabetes.
    Diabet Med. 2023 May 29:e15155. doi: 10.1111/dme.15155.
    PubMed     Abstract available

  46. MENDOZA LC, Tashkova M, Corcoy R, Dornhorst A, et al
    Pregnancy induces longitudinal changes in Urinary C-peptide Creatinine Ratio in women with type 1 diabetes.
    Diabet Med. 2023 May 25:e15154. doi: 10.1111/dme.15154.
    PubMed     Abstract available

  47. HEIKKILA EA, Pokka TM, Korpelainen R, Tossavainen PH, et al
    Level, types and determinants of physical activity in children with type 1 diabetes and their parents: A cross sectional study.
    Diabet Med. 2023 May 18:e15149. doi: 10.1111/dme.15149.
    PubMed     Abstract available

  48. ZHANG S, Mittinty M, Davis EA, Cameron E, et al
    Childhood onset type 1 diabetes in Western Australia: an update on incidence and temporal trends from 2001 to 2022.
    Diabet Med. 2023 May 16:e15148. doi: 10.1111/dme.15148.
    PubMed     Abstract available

  49. QUINN LM, Narendran P, Randell MJ, Bhavra K, et al
    General population screening for paediatric type 1 diabetes - A qualitative study of UK professional stakeholders.
    Diabet Med. 2023 May 7:e15131. doi: 10.1111/dme.15131.
    PubMed     Abstract available

  50. YU X, Fan M, Zhao X, Ding Y, et al
    Prevalence of impaired awareness of hypoglycaemia in people with diabetes mellitus: A systematic review and meta-analysis from 21 countries and regions.
    Diabet Med. 2023 May 4:e15129. doi: 10.1111/dme.15129.
    PubMed     Abstract available

  51. LAWTON J, Rankin D, Hartnell S, Lee T, et al
    Healthcare professionals' views about how pregnant women can benefit from using a closed-loop system: Qualitative study.
    Diabet Med. 2023;40:e15072.
    PubMed     Abstract available

  52. FERREY A, Ashworth G, Cabling M, Rundblad G, et al
    A thematic analysis of YouTube comments on a television documentary titled 'Diabulimia: The World's most dangerous eating disorder'.
    Diabet Med. 2023;40:e15025.
    PubMed     Abstract available

    April 2023
  53. COMMISSARIAT PV, DiMeglio LA, Kanapka LG, Laffel LM, et al
    Twelve-month Psychosocial Outcomes of Continuous Glucose Monitoring with Behavioral Support in Parents of Young Children with Type 1 Diabetes.
    Diabet Med. 2023 Apr 21:e15120. doi: 10.1111/dme.15120.
    PubMed     Abstract available

  54. HEALD AH, Stedman M, Horne L, Rea R, et al
    The change in glycaemic control immediately after the 3rd COVID-19 vaccination in people with type 1 diabetes.
    Diabet Med. 2023 Apr 21:e15119. doi: 10.1111/dme.15119.

  55. EMBAYE J, Bassi G, Dingemans AE, Doesborg L, et al
    Associations between disordered eating behaviour, diabetes distress and emotion regulation strategies in adults with type 1 diabetes: results from a Dutch-Italian cross-sectional study.
    Diabet Med. 2023 Apr 20:e15122. doi: 10.1111/dme.15122.
    PubMed     Abstract available

  56. LIBERMAN A, Shenker MN, Bello R, Yackobovitch-Gavan M, et al
    Fear of hyperglycemia in parents of children with type 1 diabetes mellitus - a multi-center multi-national study.
    Diabet Med. 2023 Apr 13:e15114. doi: 10.1111/dme.15114.
    PubMed     Abstract available

  57. JOSHI SS, Singh T, Kershaw LE, Gibb FW, et al
    Non-invasive imaging of functional pancreatic islet beta-cell mass in people with type 1 diabetes mellitus.
    Diabet Med. 2023 Apr 10:e15111. doi: 10.1111/dme.15111.
    PubMed     Abstract available

  58. FRANCESCHI R, Mozzillo E, Di Candia F, Maines E, et al
    A systematic review on the impact of commercially available hybrid closed loop systems on psychological outcomes in youths with type 1 diabetes and their parents.
    Diabet Med. 2023 Apr 8:e15099. doi: 10.1111/dme.15099.
    PubMed     Abstract available

  59. BENTON M, Baykoca J, Ismail K, Price H, et al
    Healthcare professionals' experiences in identifying and supporting mental health problems in adults living with type 1 diabetes mellitus: a qualitative study.
    Diabet Med. 2023 Apr 2:e15103. doi: 10.1111/dme.15103.
    PubMed     Abstract available

  60. MULLA K, Farag S, Moore B, Matharu S, et al
    Hyperglycaemia following immune checkpoint inhibitor therapy-Incidence, aetiology and assessment.
    Diabet Med. 2023;40:e15053.
    PubMed     Abstract available

    March 2023
  61. MACKIE T, Morrow TD, Abadula FJ, Jaser SS, et al
    Importance of Caregivers' Subjective Social Status and Neighbourhood Disadvantage for Adolescents with Type 1 Diabetes.
    Diabet Med. 2023 Mar 30:e15097. doi: 10.1111/dme.15097.
    PubMed     Abstract available

  62. DESHMUKH H, Adeleke KA, Ssemmondo E, Wilmot EG, et al
    Ethnic disparities in people accessing Free-Style Libre in the United Kingdom: Insights from the Association of British Clinical Diabetologists audit.
    Diabet Med. 2023 Mar 30:e15095. doi: 10.1111/dme.15095.

  63. BOUGHTON CK, Hartnell S, Hobday N, Lake A, et al
    Implementation of fully closed-loop insulin delivery for inpatients with diabetes: real-world outcomes.
    Diabet Med. 2023 Mar 22:e15092. doi: 10.1111/dme.15092.
    PubMed     Abstract available

  64. GRIFFIN TP, Gallen G, Hartnell S, Crabtree T, et al
    UK's Association of British Clinical Diabetologist's Diabetes Technology Network (ABCD-DTN): Best practice guide for Hybrid Closed-Loop Therapy.
    Diabet Med. 2023 Mar 18:e15078. doi: 10.1111/dme.15078.
    PubMed     Abstract available

  65. HODNEKVAM K, Iversen HH, Gani O, Brunborg C, et al
    Do adolescents and emerging adults receive the diabetes care they truly need? A nationwide study of the quality of diabetes health care during the transition from paediatric to adult care.
    Diabet Med. 2023 Mar 18:e15091. doi: 10.1111/dme.15091.
    PubMed     Abstract available

  66. STUCKEY HL, Desai U, Mitchell BD, Pearson TL, et al
    "Didn't See the Need": Misperceptions about glucagon from the perspectives of people with diabetes and their caregivers.
    Diabet Med. 2023 Mar 16:e15084. doi: 10.1111/dme.15084.
    PubMed     Abstract available

  67. STEENKAMP DW, Piarulli A, Middelbeek RJW, Wolpert HA, et al
    Severe hypoglycaemia while using a hybrid closed-loop insulin pump system: A reminder of the continued importance of patient education for pre-emptive hypoglycaemia mitigation.
    Diabet Med. 2023;40:e14975.

    February 2023
  68. DUE-CHRISTENSEN M, Bruun LD, Joensen LE, Norgaard O, et al
    Psychosocial aspects and perspectives of adult-onset type 1 diabetes: a systematic scoping review.
    Diabet Med. 2023 Feb 20:e15073. doi: 10.1111/dme.15073.
    PubMed     Abstract available

  69. CHATWIN H, Broadley M, de Galan B, Bazelmans E, et al
    Effectiveness of educational and behavioural interventions for reducing fear of hypoglycaemia among adults with type 1 diabetes: Systematic review and meta-analyses.
    Diabet Med. 2023 Feb 17:e15071. doi: 10.1111/dme.15071.
    PubMed     Abstract available

  70. SHAH N, Deshmukh H, Wilmot EG, Patmore J, et al
    The long-term impact of glucose monitoring with the FreeStyle Libre on glycaemic control and hypoglycaemia awareness in people with insulin-dependent diabetes mellitus: Insights from the Association of British Clinical Diabetologists national audit.
    Diabet Med. 2023 Feb 16:e15070. doi: 10.1111/dme.15070.
    PubMed     Abstract available

  71. HITT TA, Hershey JA, Olivos-Stewart D, Forth E, et al
    The Impact of Fear of Hypoglycaemia on Sleep in Adolescents with Type I Diabetes.
    Diabet Med. 2023 Feb 14:e15066. doi: 10.1111/dme.15066.
    PubMed     Abstract available

  72. RYTTER K, Madsen KP, Andersen HU, Hommel E, et al
    Associations between insulin pump self-management and HbA1c in type 1 diabetes.
    Diabet Med. 2023 Feb 14:e15068. doi: 10.1111/dme.15068.
    PubMed     Abstract available

  73. THOMSON I, Anderson N, Bath L, Kiff S, et al
    Type 1 diabetes incidence in Scotland between 2006 and 2019.
    Diabet Med. 2023 Feb 14:e15069. doi: 10.1111/dme.15069.
    PubMed     Abstract available

  74. ACCIAROLI G, van der Linden J, Chao C, Walker TC, et al
    Longitudinal analysis of users transitioning from the Dexcom G5 to the G6 RT-CGM system in Germany, Sweden and the United Kingdom (2018-2020).
    Diabet Med. 2023;40:e14946.
    PubMed     Abstract available

    January 2023
  75. GU J, Chaput K, Dunlop A, Booth J, et al
    Existing standardised questionnaires do not adequately capture quality-of-life outcomes of greatest importance for those living with type 1 diabetes in pregnancy.
    Diabet Med. 2023 Jan 22:e15044. doi: 10.1111/dme.15044.
    PubMed     Abstract available

  76. ALI N, El Hamdaoui S, Schouwenberg BJ, Tack CJ, et al
    Fall in prevalence of impaired awareness of hypoglycaemia in individuals with type 1 diabetes.
    Diabet Med. 2023 Jan 16:e15042. doi: 10.1111/dme.15042.
    PubMed     Abstract available

  77. EHRMANN D, Chatwin H, Schmitt A, Soeholm U, et al
    Reduced heart rate variability in people with type 1 diabetes and elevated diabetes distress: Results from the longitudinal observational DIA-LINK1 study.
    Diabet Med. 2023 Jan 10:e15040. doi: 10.1111/dme.15040.
    PubMed     Abstract available

  78. DIAZ JVR, Figueroa J, Felner EI
    A Pilot Study of Mealtime Insulin Administration and Parental Stress in Youth with New-Onset Type 1 Diabetes.
    Diabet Med. 2023 Jan 8:e15039. doi: 10.1111/dme.15039.
    PubMed     Abstract available

  79. OLIVER N, Chow E, Luk AOY, Murphy H, et al
    Applications of continuous glucose monitoring across settings and populations: report from the 23(rd) Hong Kong Diabetes and Cardiovascular Risk Factors - East Meets West Symposium.
    Diabet Med. 2023 Jan 8:e15038. doi: 10.1111/dme.15038.
    PubMed     Abstract available

    December 2022
  80. JLALI I, Heyman E, Matran R, Marais G, et al
    Respiratory function in uncomplicated type 1 diabetes: blunted during exercise even though normal at rest!
    Diabet Med. 2022 Dec 31:e15036. doi: 10.1111/dme.15036.
    PubMed     Abstract available

  81. TASCI I
    The Role of Glycated Hemoglobin in Clinical Decision-Making of Diabetes Overtreatment.
    Diabet Med. 2022 Dec 19:e15021. doi: 10.1111/dme.15021.

  82. KUBILAY E, Trawley S, Ward GM, Fourlanos S, et al
    Lived experience of older adults with type 1 diabetes using closed-loop automated insulin delivery in a randomised trial.
    Diabet Med. 2022 Dec 5:e15020. doi: 10.1111/dme.15020.
    PubMed     Abstract available

    November 2022
  83. NG SM, Wright NP, Yardley D, Campbell F, et al
    Real world use of hybrid-closed loop in children and young people with type 1 diabetes mellitus - A national health service pilot initiative in England.
    Diabet Med. 2022 Nov 24:e15015. doi: 10.1111/dme.15015.
    PubMed     Abstract available

  84. FERRY P, Dunne FP, Meagher C, Lennon R, et al
    Attendance at pre-pregnancy care clinics for women with type 1 diabetes: a scoping review.
    Diabet Med. 2022 Nov 21:e15014. doi: 10.1111/dme.15014.
    PubMed     Abstract available

  85. FLYNN AC, Robertson M, Kavanagh K, Murphy HR, et al
    Pre-pregnancy Health of Women with Pre-existing Diabetes or Previous Gestational Diabetes; analysis of pregnancy risk factors and behavioural data from a digital tool.
    Diabet Med. 2022 Nov 20:e15008. doi: 10.1111/dme.15008.
    PubMed     Abstract available

  86. VOLLENBROCK CE, Mul D, Dekker P, Birnie E, et al
    Fasting and meal-stimulated serum C-peptide in long-standing type 1 diabetes mellitus.
    Diabet Med. 2022 Nov 18:e15012. doi: 10.1111/dme.15012.
    PubMed     Abstract available

  87. HORNUNG RJ, Reed PW, Gunn AJ, Albert B, et al
    Transition from paediatric to adult care in young people with diabetes; A structured program from a regional diabetes service, Auckland, New Zealand.
    Diabet Med. 2022 Nov 18:e15011. doi: 10.1111/dme.15011.
    PubMed     Abstract available

  88. MOLVAER AK, Iversen MM, Igland J, Peyrot M, et al
    Metabolic predictors of pain, fatigue, depression and quality of life in people with long-term type 1 diabetes - the Dialong study.
    Diabet Med. 2022 Nov 17:e15009. doi: 10.1111/dme.15009.
    PubMed     Abstract available

  89. SOON WHK, Fournier PA, Abraham MB, Smith GJ, et al
    Reproducibility of plasma glucose responses to moderate-intensity exercise in individuals with Type 1 diabetes.
    Diabet Med. 2022 Nov 7:e15000. doi: 10.1111/dme.15000.
    PubMed     Abstract available

    October 2022
  90. ISITT JJ, Roze S
    Long-term cost-effectiveness of Dexcom G6 real-time continuous glucose monitoring system in people with type 1 diabetes in Australia: Response to letter from Hellmund, Richard and Welsh, Zoe.
    Diabet Med. 2022 Oct 21:e14989. doi: 10.1111/dme.14989.

  91. HELLMUND R, Welsh Z
    "Long-term cost-effectiveness of Dexcom G6 real-time continuous glucose monitoring system in people with type 1 diabetes in Australia: comments on J. J. Isitt et al."
    Diabet Med. 2022 Oct 21:e14988. doi: 10.1111/dme.14988.

  92. NORGARD BM, Zegers FD, Juhl CB, Kjeldsen J, et al
    Diabetes mellitus and the risk of post-acute COVID-19 hospitalizations - a nationwide cohort study.
    Diabet Med. 2022 Oct 21:e14986. doi: 10.1111/dme.14986.
    PubMed     Abstract available

  93. ECKSTEIN ML, Aziz F, Aberer F, Bockel S, et al
    Blood glucose response to running or cycling in individuals with type 1 diabetes: a systematic review and meta-analysis.
    Diabet Med. 2022 Oct 18:e14981. doi: 10.1111/dme.14981.
    PubMed     Abstract available

  94. WILLIAMS CL, Aitken RJ, Wilson IV, Mortimer GLM, et al
    The measurement of autoantibodies to insulin informs diagnosis of diabetes in a childhood population negative for other autoantibodies.
    Diabet Med. 2022 Oct 17:e14979. doi: 10.1111/dme.14979.
    PubMed     Abstract available

    Remembrance of things past: The consequences of recurrent hypoglycaemia in diabetes.
    Diabet Med. 2022 Oct 17:e14973. doi: 10.1111/dme.14973.
    PubMed     Abstract available

  96. EISSA MR, Benaissa M, Good T, Hui Z, et al
    Analysis of real-world capillary blood glucose data to help reduce HbA1c and hypoglycaemia in type 1 diabetes: evidence in favour of using percentage of readings in target and coefficient of variation.
    Diabet Med. 2022 Oct 9:e14972. doi: 10.1111/dme.14972.
    PubMed     Abstract available

    September 2022
  97. SHANG X, Hill E, Liu J, Zhu Z, et al
    Association of type 1 diabetes and age at diagnosis of type 2 diabetes with brain volume and risk of dementia in the UK Biobank: a prospective cohort study of community-dwelling participants.
    Diabet Med. 2022 Sep 30:e14966. doi: 10.1111/dme.14966.
    PubMed     Abstract available

  98. HUISMAN SD, Hendrieckx C, Bot M, Pouwer F, et al
    Prevalence, associations and health outcomes of binge eating in adults with type 1 or type 2 diabetes: Results from Diabetes MILES - The Netherlands.
    Diabet Med. 2022 Sep 9. doi: 10.1111/dme.14953.
    PubMed     Abstract available

  99. DIVILLY P, Zaremba N, Mahmoudi Z, Soholm U, et al
    Hypo-METRICS: Hypoglycaemia-MEasurement, ThResholds and ImpaCtS-A multi-country clinical study to define the optimal threshold and duration of sensor-detected hypoglycaemia that impact the experience of hypoglycaemia, quality of life and health econom
    Diabet Med. 2022;39:e14892.
    PubMed     Abstract available

  100. STAFL L, Benham JL, Frehlich L, Donovan LE, et al
    Missed Antenatal Diabetes Care Appointments and Neonatal Outcomes for Pregnancies with Type 1 and Type 2 Diabetes.
    Diabet Med. 2022 Sep 1. doi: 10.1111/dme.14950.
    PubMed     Abstract available

    August 2022
  101. DESHMUKH H, Wilmot E, Pieri B, Choudhary P, et al
    Time in Range (TIR) following flash glucose monitoring; relationship with glycaemic control, diabetes-related distress (DRD) and resource utilisation in the Association of British Clinical Diabetologists (ABCD) national audit.
    Diabet Med. 2022 Aug 26:e14942. doi: 10.1111/dme.14942.
    PubMed     Abstract available

  102. SPEIGHT J, Choudhary P, Wilmot EG, Hendrieckx C, et al
    Impact of glycaemic technologies on quality of life and related outcomes in adults with type 1 diabetes: a narrative review.
    Diabet Med. 2022 Aug 25:e14944. doi: 10.1111/dme.14944.
    PubMed     Abstract available

  103. BROWN RE, Chu L, Norman GJ, Abitbol A, et al
    Real-world glycaemic outcomes in adult persons with type 1 diabetes using a real-time continuous glucose monitor compared to an intermittently scanned glucose monitor: A retrospective observational study from the Canadian LMC diabetes registry (REAL-C
    Diabet Med. 2022 Aug 18:e14937. doi: 10.1111/dme.14937.
    PubMed     Abstract available

    July 2022
  104. TANENBAUM ML, Zaharieva DP, Addala A, Prahalad P, et al
    "Much more convenient, just as effective:" Experiences of starting continuous glucose monitoring remotely following Type 1 diabetes diagnosis.
    Diabet Med. 2022 Jul 28:e14923. doi: 10.1111/dme.14923.
    PubMed     Abstract available

  105. ITZKOVITZ A, Maggio V, Roy-Fleming A, Legault L, et al
    Nutrition and Food Literacy among Young Canadian Adults Living with Type 1 Diabetes.
    Diabet Med. 2022 Jul 23:e14921. doi: 10.1111/dme.14921.
    PubMed     Abstract available

  106. KERO J, Koskenniemi JJ, Karsikas S, Pokka T, et al
    INnoVative trial design for testing the Efficacy, Safety, and Tolerability of 6-month treatment with incretin-based therapy to prevent type 1 DIAbetes in autoantibody positive participants: a protocol for three parallel double-blind randomised control
    Diabet Med. 2022 Jul 7:e14913. doi: 10.1111/dme.14913.
    PubMed     Abstract available

  107. NG SM, Katkat N, Day H, Hubbard R, et al
    Real-world prospective observational single-centre study: Hybrid closed loop improves HbA1c, time-in-range and quality of life for children, young people and their carers.
    Diabet Med. 2022;39:e14863.
    PubMed     Abstract available

  108. MESSER LH, Vigers T, Pyle L, Fivekiller E, et al
    Novel predictors of daily fluctuations in glycemia and self-management in adolescents and young adults with type 1 diabetes.
    Diabet Med. 2022 Jul 1:e14910. doi: 10.1111/dme.14910.
    PubMed     Abstract available

    June 2022
  109. ROBERTS A, Fried L, Dart J, de Bock M, et al
    Hybrid closed loop therapy with a first-generation system increases confidence and independence in diabetes management in youth with Type 1 diabetes.
    Diabet Med. 2022 Jun 27:e14907. doi: 10.1111/dme.14907.
    PubMed     Abstract available

  110. FALLON C, Jones E, Oliver N, Reddy M, et al
    The impact of socio-economic deprivation on access to diabetes technology in adults with type 1 diabetes.
    Diabet Med. 2022 Jun 25:e14906. doi: 10.1111/dme.14906.
    PubMed     Abstract available

  111. SONG SH, Frier BM
    Young-onset type 2 diabetes: a neglected group requiring urgent attention.
    Diabet Med. 2022 Jun 18:e14903. doi: 10.1111/dme.14903.

  112. INNES CWD, Henshall DE, Wilson B, Poon MTC, et al
    Socioeconomic deprivation is associated with reduced efficacy of an insulin adjustment education program for people with type 1 diabetes.
    Diabet Med. 2022 Jun 18:e14902. doi: 10.1111/dme.14902.
    PubMed     Abstract available

    May 2022
  113. ABRAIMOVA A, Besancon S, Portocarrero J, Ramaiya K, et al
    Management of type 1 diabetes in low- and middle-income countries: comparative health system assessments in Kyrgyzstan, Mali, Peru and Tanzania.
    Diabet Med. 2022 May 27:e14891. doi: 10.1111/dme.14891.
    PubMed     Abstract available

  114. FANG X, Jin L, Tang M, Lu W, et al
    Common single-nucleotide polymorphisms Combined with a Genetic Risk Score Provide New Insights Regarding the Etiology of Gestational Diabetes Mellitus.
    Diabet Med. 2022 May 19:e14885. doi: 10.1111/dme.14885.
    PubMed     Abstract available

  115. LEE VTY, Poynten A, Depczynski B
    Continuous Glucose Monitoring to Assess Glucose Variability in Type 3c Diabetes.
    Diabet Med. 2022 May 15:e14882. doi: 10.1111/dme.14882.
    PubMed     Abstract available

  116. JOENSEN LE, Schultz AA, Madsen KP, Persson F, et al
    Flexible inclusion of dialogue about psychosocial aspects of life with type 1 diabetes in routine consultations - a study of a questionnaire-based dialogue tool to promote person-centered support.
    Diabet Med. 2022 May 13:e14881. doi: 10.1111/dme.14881.
    PubMed     Abstract available

  117. CLEAL B, Willaing I
    User-driven, open-source diabetes technology: Challenges and opportunities in diabetes care?
    Diabet Med. 2022;39:e14836.

  118. VALLIS M, Holt RIG
    User-driven open-source artificial pancreas systems and patient-reported outcomes: A missed opportunity?
    Diabet Med. 2022;39:e14797.
    PubMed     Abstract available

  119. CAMERLINGO N, Vettoretti M, Sparacino G, Facchinetti A, et al
    Choosing the duration of continuous glucose monitoring for reliable assessment of time in range: A new analytical approach to overcome the limitations of correlation-based methods.
    Diabet Med. 2022;39:e14758.
    PubMed     Abstract available

  120. CROCKET H, Lewis DM, Burnside M, Faherty A, et al
    Learning challenges of healthcare professionals supporting open-source automated insulin delivery.
    Diabet Med. 2022;39:e14750.
    PubMed     Abstract available

  121. CROCKET H, Elbashy MM, Kavanagh T, Styles S, et al
    Parental experiences of short term supported use of a do-it-yourself continuous glucose monitor (DIYrtCGM): A qualitative study.
    Diabet Med. 2022;39:e14731.
    PubMed     Abstract available

  122. DICKSON R, Bell J, Dar A, Downey L, et al
    #WeAreNotWaiting DIY artificial pancreas systems and challenges for the law.
    Diabet Med. 2022;39:e14715.
    PubMed     Abstract available

  123. LEWIS DM
    Errors of commission or omission: The net risk safety analysis conversation we should be having around automated insulin delivery systems.
    Diabet Med. 2022;39:e14687.
    PubMed     Abstract available

    April 2022
  124. TATOVIC D, Jones AG, Evans C, Long AE, et al
    Diagnosing Type 1 diabetes in adults: guidance from the UK T1D Immunotherapy consortium.
    Diabet Med. 2022 Apr 29:e14862. doi: 10.1111/dme.14862.

  125. ARIF S, Yusuf N, Domingo-Vila C, Liu YF, et al
    Evaluating T cell responses prior to the onset of type 1 diabetes.
    Diabet Med. 2022 Apr 28:e14860. doi: 10.1111/dme.14860.
    PubMed     Abstract available

  126. SUGRUE M, Liddy AM, McDermott JH, Sreenan S, et al
    Diabetic Ketoacidosis as a Unique Presentation of Cystic Fibrosis.
    Diabet Med. 2022 Apr 25:e14859. doi: 10.1111/dme.14859.

  127. BUSKOVEN MEH, Kjorholt EKH, Strandberg RB, Softeland E, et al
    Sexual dysfunction in women with type 1 diabetes in Norway: A qualitative study of women's experiences.
    Diabet Med. 2022 Apr 23:e14856. doi: 10.1111/dme.14856.
    PubMed     Abstract available

  128. ELBALSHY M, Haszard J, Smith H, Kuroko S, et al
    Effect of Divergent Continuous Glucose Monitoring Technologies on Glycaemic Control in Type 1 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomised Controlled Trials.
    Diabet Med. 2022 Apr 20:e14854. doi: 10.1111/dme.14854.
    PubMed     Abstract available

  129. MOSHAGE Y, Rodrigues F, White M, Cameron F, et al
    A pragmatic real world trial examining the impact of an alteration of prescribing practice at diagnosis in pediatric type 1 diabetes mellitus.
    Diabet Med. 2022 Apr 15:e14849. doi: 10.1111/dme.14849.

  130. MACKENZIE SC, Cumming KM, Mehar S, Wilson L, et al
    Education at Scale: Improvements in Type 1 Diabetes Self-Management Following a Massive Open Online Course (MOOC).
    Diabet Med. 2022 Apr 15:e14842. doi: 10.1111/dme.14842.

    March 2022
  131. DINNEEN SF, McMorrow L
    Re-framing type 1 diabetes care through Open-source Automated Insulin Delivery: "The (expert) patient will see you now, doctor".
    Diabet Med. 2022 Mar 31:e14839. doi: 10.1111/dme.14839.

  132. JONES PM, Persaud SJ
    beta-cell replacement therapy for type 1 diabetes: closer and closer.
    Diabet Med. 2022 Mar 27:e14834. doi: 10.1111/dme.14834.

  133. SEIDEL-JACOBS E, Ptushkina V, Strassburger K, Icks A, et al
    Socioeconomic Inequalities in Glycaemic Control in Recently Diagnosed Adults with Type 1 and Type 2 Diabetes.
    Diabet Med. 2022 Mar 24:e14833. doi: 10.1111/dme.14833.
    PubMed     Abstract available

  134. MASHARANI U, Strycker LA, Fisher L
    The ubiquity of diabetes distress among adults with type 1 diabetes in an urban, academic practice: a template for intervention.
    Diabet Med. 2022 Mar 24:e14832. doi: 10.1111/dme.14832.
    PubMed     Abstract available

  135. ISITT JJ, Roze S, Tilden D, Arora N, et al
    Long-term cost-effectiveness of Dexcom G6 real-time continuous glucose monitoring system in people with type 1 diabetes IN Australia.
    Diabet Med. 2022 Mar 17:e14831. doi: 10.1111/dme.14831.
    PubMed     Abstract available

  136. JESSICA E, Anna-Maria L, Sofia C
    Parental smoking, type 1 diabetes, and islet antibody positivity in the offspring: a systematic review and meta-analysis.
    Diabet Med. 2022 Mar 15:e14830. doi: 10.1111/dme.14830.
    PubMed     Abstract available

  137. HART RI, Kimbell B, Rankin D, Allen JM, et al
    Parents' experiences of using remote monitoring technology to manage type 1 diabetes in very young children during a clinical trial: qualitative study.
    Diabet Med. 2022 Mar 11:e14828. doi: 10.1111/dme.14828.
    PubMed     Abstract available

    February 2022
  138. BASHIR B, Elisaus P, Grigoriadou VC, Urwin A, et al
    Real world effectiveness of clinically approved hybrid closed loop systems in a UK Secondary Care Diabetes Service.
    Diabet Med. 2022 Feb 18:e14816. doi: 10.1111/dme.14816.

  139. TAYLOR G, Shaw AC, Smith K, Wason J, et al
    Capturing the real world benefit of residual beta-cell function during clinically important time-periods in established Type 1 diabetes.
    Diabet Med. 2022 Feb 18:e14814. doi: 10.1111/dme.14814.
    PubMed     Abstract available

  140. DYBJER E, Dahl Aslan AK, Engstrom G, Nilsson ED, et al
    Type 1 diabetes, cognitive ability and incidence of cardiovascular disease and death over 60 years of follow-up time in men.
    Diabet Med. 2022 Feb 7:e14806. doi: 10.1111/dme.14806.
    PubMed     Abstract available

  141. ZAFRA-TANAKA JH, Beran D, Bernabe-Ortiz A
    Health system responses for type 1 diabetes: A scoping review.
    Diabet Med. 2022 Feb 5:e14805. doi: 10.1111/dme.14805.
    PubMed     Abstract available

    January 2022
  142. CARLSON NE, Horton KW, Hokanson JE, Cleary PA, et al
    Weight gain trajectories and obesity rates in intensive and conventional treatments of Type 1 diabetes from the DCCT compared to a control population without diabetes.
    Diabet Med. 2022 Jan 18:e14794. doi: 10.1111/dme.14794.
    PubMed     Abstract available

  143. PATEL R, Crabtree T, Taylor N, Langeland L, et al
    Safety and effectiveness of Do-It-Yourself Artificial Pancreas System (DIYAPS) compared with continuous subcutaneous insulin infusions (CSII) in combination with Free Style Libre (FSL) in people with Type 1 diabetes.
    Diabet Med. 2022 Jan 16:e14793. doi: 10.1111/dme.14793.
    PubMed     Abstract available

  144. BAHRAMI J, Tomlinson G, Murphy HR, Feig DS, et al
    Impaired Awareness of Hypoglycaemia in Women with Type 1 Diabetes in Pregnancy: Hypoglycaemia fear, glycaemic and pregnancy outcomes.
    Diabet Med. 2022 Jan 14:e14789. doi: 10.1111/dme.14789.
    PubMed     Abstract available

  145. LAURBERG T, Schougaard LMV, Hjollund NHI, Lomborg KE, et al
    Randomized Controlled Study to Evaluate the Impact of Flexible Patient-controlled Visits in People with Type 1 Diabetes: The DiabetesFlex Trial.
    Diabet Med. 2022 Jan 13:e14791. doi: 10.1111/dme.14791.
    PubMed     Abstract available

  146. DE LEUR K, Vollenbrock C, Dekker P, de Vries M, et al
    How low is really low? Comparison of two C-peptide assays to establish residual C-peptide production in type 1 diabetes.
    Diabet Med. 2022 Jan 6:e14785. doi: 10.1111/dme.14785.
    PubMed     Abstract available

  147. BOCHANEN N, Decochez K, Heleu E, Cuypers J, et al
    Lipohypertrophy Monitoring Study (LIMO): Effect of single use of 4 mm pen needles combined with education on injection site rotation on glycaemic control: Confirmation of an unpleasant truth.
    Diabet Med. 2022;39:e14672.
    PubMed     Abstract available

    December 2021
  148. LADD JM, Reeves-Latour J, Dasgupta K, Bell LE, et al
    Toward a better understanding of transition from paediatric to adult care in type 1 diabetes: a qualitative study of adolescents.
    Diabet Med. 2021 Dec 29:e14781. doi: 10.1111/dme.14781.
    PubMed     Abstract available

  149. SHARMA S, Gillespie P, Hobbins A, Dinneen SF, et al
    Estimating the Cost of Type 1 Diabetes in Ireland.
    Diabet Med. 2021 Dec 27:e14779. doi: 10.1111/dme.14779.
    PubMed     Abstract available

  150. OVERGAARD M, Ravnsborg T, Lohse Z, Bytoft B, et al
    Apolipoprotein D and transthyretin are reduced in female adolescent offspring of women with type 1 diabetes: the EPICOM study.
    Diabet Med. 2021 Dec 23:e14776. doi: 10.1111/dme.14776.
    PubMed     Abstract available

  151. HEALD AH, Stedman M, Horne L, Rea R, et al
    The change in glycaemic control immediately after COVID-19 vaccination in people with type 1 diabetes.
    Diabet Med. 2021 Dec 22:e14774. doi: 10.1111/dme.14774.
    PubMed     Abstract available

  152. FREDRIKSSON M, Persson E, Dahlquist G, Mollsten A, et al
    Risk of cancer in young and middle-aged adults with childhood-onset type 1 diabetes in Sweden - a prospective cohort study.
    Diabet Med. 2021 Dec 19:e14771. doi: 10.1111/dme.14771.
    PubMed     Abstract available

  153. PRIGGE R, McKnight JA, Wild SH, Haynes A, et al
    International comparison of glycaemic control in people with type 1 diabetes: an update and extension.
    Diabet Med. 2021 Dec 10:e14766. doi: 10.1111/dme.14766.
    PubMed     Abstract available

  154. RAJ A, Bansiya V, Evans ML, Boughton CK, et al
    Implementation of dapagliflozin as adjunctive therapy in type 1 diabetes: A single centre real-world experience.
    Diabet Med. 2021 Dec 9:e14764. doi: 10.1111/dme.14764.

  155. CARREON SA, Cao VT, Anderson BJ, Thompson DI, et al
    "I Don't Sleep Through the Night": Qualitative Study of Sleep in Type 1 Diabetes.
    Diabet Med. 2021 Dec 7:e14763. doi: 10.1111/dme.14763.
    PubMed     Abstract available

  156. FORDE H, Choudhary P, Lumb A, Wilmot E, et al
    Current provision and HCP experiences of remote care delivery and diabetes technology training for people with type 1 diabetes in the UK during the Covid-19 pandemic.
    Diabet Med. 2021 Dec 4:e14755. doi: 10.1111/dme.14755.
    PubMed     Abstract available

  157. ROSE S, Styles SE, Wiltshire EJ, Stanley J, et al
    Use of intermittently scanned continuous glucose monitoring in young people with high-risk type 1 diabetes - extension phase outcomes following a 6-month randomised control trial.
    Diabet Med. 2021 Dec 4:e14756. doi: 10.1111/dme.14756.
    PubMed     Abstract available

  158. MERCHANT HJ, McNeilly AD
    Hypoglycaemia: Still the main drawback of insulin 100 years on: "From man to mouse".
    Diabet Med. 2021;38:e14721.
    PubMed     Abstract available

  159. THABIT H, Lal R, Leelarathna L
    Automated insulin dosing systems: Advances after a century of insulin.
    Diabet Med. 2021;38:e14695.
    PubMed     Abstract available

    November 2021
  160. FRIEL KM, Gillespie P, Coates V, McCauley C, et al
    Estimating and Examining the Costs of Inpatient Diabetes Care in an Irish Public Hospital.
    Diabet Med. 2021 Nov 28:e14753. doi: 10.1111/dme.14753.
    PubMed     Abstract available

  161. PROTHERO L, Lawrenson JG, Cartwright M, Crosby-Nwaobi R, et al
    Barriers and enablers to diabetic eye screening attendance: an interview study with young adults with type 1 diabetes.
    Diabet Med. 2021 Nov 27:e14751. doi: 10.1111/dme.14751.
    PubMed     Abstract available

  162. ZAREMBA N, Robert G, Allan J, Harrison A, et al
    Developing a novel intervention for type 1 diabetes and disordered eating using a participatory action design process: Safe management of people with Type 1 diabetes and EAting Disorders studY (STEADY).
    Diabet Med. 2021 Nov 25:e14749. doi: 10.1111/dme.14749.
    PubMed     Abstract available

  163. DIGUISTO C, Strachan MW, Churchill D, Ayman G, et al
    A Study of Diabetic Ketoacidosis in the Pregnant Population in the United Kingdom. Investigating the incidence, aetiology, management and outcomes.
    Diabet Med. 2021 Nov 15:e14743. doi: 10.1111/dme.14743.
    PubMed     Abstract available

  164. KNOLL C, Peacock S, Waldchen M, Cooper D, et al
    Real-world Evidence on Clinical Outcomes of People with Type 1 Diabetes Using Open-Source and Commercial Automated Insulin Dosing Systems: A Systematic Review.
    Diabet Med. 2021 Nov 12:e14741. doi: 10.1111/dme.14741.
    PubMed     Abstract available

  165. JONES CJ, O'Donnell N, John M, Cooke D, et al
    PaRent InterventiOn to pRevent dIsordered eating in children with TYpe 1 diabetes (PRIORITY): Study protocol for a feasibility randomised controlled trial.
    Diabet Med. 2021 Nov 6:e14738. doi: 10.1111/dme.14738.
    PubMed     Abstract available

  166. VENKATESH N, Astbury N, Thomas MC, Rosado CJ, et al
    Severe acute respiratory syndrome coronavirus 2 as a potential cause of type 1 diabetes facilitated by spike protein receptor binding domain attachment to human islet cells: An illustrative case study and experimental data.
    Diabet Med. 2021;38:e14608.
    PubMed     Abstract available

    October 2021
  167. YEOH E, Png D, Koh PL, Sum CF, et al
    Glucose Awareness to Motivate and Enable Solutions (GAMES) in Diabetes Mellitus using Flash Glucose Monitoring: A Clinical Programme.
    Diabet Med. 2021 Oct 26:e14733. doi: 10.1111/dme.14733.
    PubMed     Abstract available

  168. TIENHAARA E, Falck AAK, Pokka TM, Tossavainen PH, et al
    The natural history of emerging diabetic retinopathy and microalbuminuria from prepuberty to early adulthood in Type 1 diabetes: A 19-year prospective clinical follow-up study.
    Diabet Med. 2021 Oct 23:e14732. doi: 10.1111/dme.14732.
    PubMed     Abstract available

  169. NARENDRAN P, Tomlinson C, Beese S, Sharma P, et al
    A systematic review and meta-analysis of interventions to preserve insulin-secreting beta cell function in people newly diagnosed with type 1 diabetes: results from intervention studies aimed at improving glucose control.
    Diabet Med. 2021 Oct 22:e14730. doi: 10.1111/dme.14730.
    PubMed     Abstract available

  170. CHATWIN H, Broadley M, Hendrieckx C, Carlton J, et al
    Unmet Support Needs Relating to Hypoglycaemia Among Adults with Type 1 Diabetes: Results of a Multi-Country Web-Based Qualitative Study.
    Diabet Med. 2021 Oct 19:e14727. doi: 10.1111/dme.14727.
    PubMed     Abstract available

  171. DE FRANCO E
    Neonatal diabetes caused by disrupted pancreatic and beta cell development.
    Diabet Med. 2021 Oct 19:e14728. doi: 10.1111/dme.14728.
    PubMed     Abstract available

  172. PASQUINI S, Rinaldi E, Da Prato G, Csermely A, et al
    Growing up with Type 1 Diabetes Mellitus: data from the Verona Diabetes Transition Project.
    Diabet Med. 2021 Oct 17:e14719. doi: 10.1111/dme.14719.
    PubMed     Abstract available

  173. GILLESPIE KM, Fareed R, Mortimer GL
    Four decades of the Bart's Oxford study; improved tests to predict type 1 diabetes.
    Diabet Med. 2021 Oct 16:e14717. doi: 10.1111/dme.14717.
    PubMed     Abstract available

  174. AFI LESLIE K, Richardson SJ, Russell MA, Morgan NG, et al
    Expression of CD47 in the pancreatic beta-cells of young people with recent-onset type 1 diabetes varies according to disease endotype.
    Diabet Med. 2021 Oct 15:e14724. doi: 10.1111/dme.14724.
    PubMed     Abstract available

  175. LONG AE, George G, Williams CL
    Persistence of Islet Autoantibodies after diagnosis in Type 1 Diabetes.
    Diabet Med. 2021 Oct 6:e14712. doi: 10.1111/dme.14712.
    PubMed     Abstract available

  176. SCHIPP J, Skinner TC, Holloway E, Scibilia R, et al
    'We're all on the same team'. Perspectives on the future of artificial pancreas systems by adults in Australia with type 1 diabetes using open-source technologies: A qualitative study.
    Diabet Med. 2021 Oct 2:e14708. doi: 10.1111/dme.14708.
    PubMed     Abstract available

  177. HAUGSTVEDT A, Jorgensen J, Strandberg RB, Nilsen RM, et al
    Sexual dysfunction in women with type 1 diabetes in Norway: a cross-sectional study on prevalence and associations with physical and psychosocial complications.
    Diabet Med. 2021 Oct 1:e14704. doi: 10.1111/dme.14704.
    PubMed     Abstract available

  178. COMMISSARIAT PV, Volkening LK, Butler DA, Dassau E, et al
    Innovative features and functionalities of an artificial pancreas system: What do youth and parents want?
    Diabet Med. 2021;38:e14492.
    PubMed     Abstract available

    September 2021
  179. MORK FCB, Madsen JOB, Jensen AK, Hall GV, et al
    Differences in Insulin Sensitivity in the Partial Remission Phase of Childhood Type 1 Diabetes; a longitudinal cohort study.
    Diabet Med. 2021 Sep 26:e14702. doi: 10.1111/dme.14702.
    PubMed     Abstract available

  180. TATOVIC D, Dayan CM
    Replacing insulin with immunotherapy: time for a paradigm change in Type 1 Diabetes.
    Diabet Med. 2021 Sep 23:e14696. doi: 10.1111/dme.14696.
    PubMed     Abstract available

    August 2021
  181. VAN CAUWENBERGHE J, Enzlin P, Nefs G, Ruige J, et al
    Prevalence of and risk factors for sexual dysfunctions in adults with type 1 or type 2 diabetes: Results from Diabetes MILES - Flanders.
    Diabet Med. 2021 Aug 25:e14676. doi: 10.1111/dme.14676.
    PubMed     Abstract available

  182. CORDON NM, Smart CE, Smith GJ, Davis EA, et al
    The relationship between meal carbohydrate quantity and the insulin to carbohydrate ratio required to maintain glycaemia is non-linear in young people with type 1 diabetes : A randomized crossover trial.
    Diabet Med. 2021 Aug 20:e14675. doi: 10.1111/dme.14675.
    PubMed     Abstract available

  183. LINDKVIST EB, Thorsen SU, Paulsrud C, Thingholm PR, et al
    Association of type 1 diabetes and educational achievement in 16-20-year-olds: A Danish nationwide register study.
    Diabet Med. 2021 Aug 18:e14673. doi: 10.1111/dme.14673.
    PubMed     Abstract available

    July 2021
  184. JENSEN MV, Broadley M, Speight J, Scope A, et al
    The impact of hypoglycaemia on the quality of life of family members of adults with type 1 or type 2 diabetes - a qualitative systematic review.
    Diabet Med. 2021 Jul 30:e14666. doi: 10.1111/dme.14666.
    PubMed     Abstract available

  185. JOENSEN LE, Steenberg JL, Madsen KP, Willaing I, et al
    What people with diabetes in Denmark worry about during the COVID-19 pandemic: a longitudinal study of the first three months of the COVID-19 pandemic.
    Diabet Med. 2021 Jul 30:e14665. doi: 10.1111/dme.14665.
    PubMed     Abstract available

  186. ALLCOCK B, Stewart R, Jackson M
    Psychosocial factors associated with repeat diabetic ketoacidosis in people living with type 1 diabetes: A systematic review.
    Diabet Med. 2021 Jul 29:e14663. doi: 10.1111/dme.14663.
    PubMed     Abstract available

  187. VELAYUTHAM V, Benitez-Aguirre PZ, Liew G, Wong TY, et al
    Baseline extended zone retinal vascular calibers associate with sensory nerve abnormalities in adolescents with type 1 diabetes: a prospective longitudinal study.
    Diabet Med. 2021 Jul 29:e14662. doi: 10.1111/dme.14662.
    PubMed     Abstract available

  188. NAGEL KE, Dearth-Wesley T, Herman AN, Smith HG, et al
    Diabetes distress and glycaemic control in young adults with type 1 diabetes: associations by use of insulin pumps and continuous glucose monitors.
    Diabet Med. 2021 Jul 26:e14660. doi: 10.1111/dme.14660.
    PubMed     Abstract available

  189. UDUKU C, Pendolino V, Godsland I, Oliver N, et al
    Cross-sectional analysis of emergency hypoglycaemia and outcome predictors among people with diabetes in an urban population.
    Diabet Med. 2021 Jul 19:e14654. doi: 10.1111/dme.14654.
    PubMed     Abstract available

  190. CECILIA-COSTA R, Hansmann M, McGill DE, Volkening LK, et al
    Association of Executive Function Problems and Disordered Eating Behaviors in Teens with Type 1 Diabetes.
    Diabet Med. 2021 Jul 17:e14652. doi: 10.1111/dme.14652.
    PubMed     Abstract available

  191. WYLIE TA, Shah C, Burgess L, Robertson E, et al
    Optimising the use of technology to support people with diabetes: research recommendations from Diabetes UK's 2019 diabetes and technology workshop.
    Diabet Med. 2021 Jul 16:e14647. doi: 10.1111/dme.14647.
    PubMed     Abstract available

  192. SMITH TA, Marlow AA, King BR, Smart CE, et al
    Insulin strategies for dietary fat and protein in type 1 diabetes: A systematic review.
    Diabet Med. 2021 Jul 12:e14641. doi: 10.1111/dme.14641.
    PubMed     Abstract available

  193. MCGLACKEN-BYRNE SM, Drew SE, Turner K, Peters C, et al
    The SARS-CoV-2 Pandemic Is Associated With Increased Severity Of Presentation Of Childhood Onset Type 1 Diabetes Mellitus: A Multicentre Study Of The First COVID-19 Wave.
    Diabet Med. 2021 Jul 10:e14640. doi: 10.1111/dme.14640.
    PubMed     Abstract available

  194. PENNO MA, Anderson AJ, Thomson RL, McGorm K, et al
    Evaluation of protocol amendments to the Environmental Determinants of Islet Autoimmunity (ENDIA) study during the COVID-19 pandemic.
    Diabet Med. 2021 Jul 8:e14638. doi: 10.1111/dme.14638.
    PubMed     Abstract available

  195. PATTON SR, Feldman K, Majidi S, Noser A, et al
    Identifying HbA1c Trajectories and Modifiable Risk Factors of Trajectories in 5-9-year-olds with Recent-Onset Type 1 Diabetes from the United States.
    Diabet Med. 2021 Jul 8:e14637. doi: 10.1111/dme.14637.
    PubMed     Abstract available

    June 2021
  196. OZBEK BT, Modin D, Mogelvang R, Jorgensen PG, et al
    Echocardiographic predictors of long-term adverse cardiovascular outcomes in patients with and without diabetes mellitus: a follow-up analysis of the Copenhagen City Heart Study.
    Diabet Med. 2021 Jun 21:e14627. doi: 10.1111/dme.14627.
    PubMed     Abstract available

  197. HITT TA, Eisenberg J, Surrey LF, Gokli A, et al
    Clinical Case Conundrum: Hyperlactataemia in a Case of Type 1 Diabetes with Chronic Hyperglycaemia.
    Diabet Med. 2021 Jun 21:e14629. doi: 10.1111/dme.14629.
    PubMed     Abstract available

  198. KELLY CS, Berg CA, Lee Tracy E, Staylor K, et al
    Daily Experiences of Type 1 Diabetes Stress across Adulthood.
    Diabet Med. 2021 Jun 21:e14628. doi: 10.1111/dme.14628.
    PubMed     Abstract available

  199. ZABELL V, Ronne ST, Hogsgaard D, Jorgensen R, et al
    "Interventions involving own treatment choice for people living with coexisting severe mental illness and type 1 or 2 diabetes: A scoping review".
    Diabet Med. 2021 Jun 21:e14626. doi: 10.1111/dme.14626.
    PubMed     Abstract available

  200. NG SM, Evans ML
    Widening health inequalities related to Type 1 diabetes care in children and young people in the UK- a time to act now.
    Diabet Med. 2021 Jun 10:e14620. doi: 10.1111/dme.14620.
    PubMed     Abstract available

  201. MOONEY SP, Booth GL, Shulman R, Na Y, et al
    Glycemic Control in Transition-Aged Versus Early Adults with Type 1 Diabetes and the Effect of a Government-Funded Insulin Pump Program.
    Diabet Med. 2021 Jun 2:e14618. doi: 10.1111/dme.14618.
    PubMed     Abstract available

  202. HOLMAN N, Knighton P, Wild SH, Sattar N, et al
    Cohort profile: National Diabetes Audit for England and Wales.
    Diabet Med. 2021 Jun 1:e14616. doi: 10.1111/dme.14616.
    PubMed     Abstract available

  203. SHAPIRA A, Harrington KR, Goethals ER, Volkening LK, et al
    Health-Related Quality of Life (HRQOL) in Youth with Type 1 Diabetes: Associations with Multiple Comorbidities and Mental Health Conditions.
    Diabet Med. 2021 Jun 1:e14617. doi: 10.1111/dme.14617.
    PubMed     Abstract available

  204. MESSER LH, Campbell K, Pyle L, Forlenza GP, et al
    Basal-IQ technology in the real world: satisfaction and reduction of diabetes burden in individuals with type 1 diabetes.
    Diabet Med. 2021;38:e14381.
    PubMed     Abstract available

    May 2021
  205. GERA S, Longendyke RL, Minich NM, Malay S, et al
    The COVID-19 Pandemic and Associated Worsening of Diabetic Ketoacidosis Presentation in Youth.
    Diabet Med. 2021 May 30:e14610. doi: 10.1111/dme.14610.
    PubMed     Abstract available

  206. TRIKI N, Yekutiel N, Levi L, Azuri J, et al
    The effects of continuous glucose monitoring system on patient outcomes and associated costs in a real-world setting.
    Diabet Med. 2021;38:e14518.
    PubMed     Abstract available

  207. HOOGENDOORN CJ, Gonzalez JS, Schechter CB, Flattau A, et al
    Correlates of self-rated health in people with diabetic peripheral neuropathy: a longitudinal study.
    Diabet Med. 2021;38:e14383.
    PubMed     Abstract available

    April 2021
  208. BOGGISS AL, Consedine NS, Schache KR, Wallace-Boyd K, et al
    Exploring the views of adolescents with type 1 diabetes on digital mental health interventions: what functionality and content do they want?
    Diabet Med. 2021 Apr 30:e14591. doi: 10.1111/dme.14591.
    PubMed     Abstract available

  209. SLATSVE KB, Claudi T, Lappegard KT, Jenum AK, et al
    Factors associated with treatment in primary vs specialist care: A population-based study of people with type 2 and type 1 diabetes.
    Diabet Med. 2021 Apr 8:e14580. doi: 10.1111/dme.14580.
    PubMed     Abstract available

  210. PRIESTERROTH L, Grammes J, Clauter M, Kubiak T, et al
    Diabetes Technologies in People with Type 1 Diabetes mellitus and Disordered Eating: A Systematic Review on Continuous Subcutaneous Insulin Infusion, Continuous Glucose Monitoring and Automated Insulin Delivery.
    Diabet Med. 2021 Apr 7:e14581. doi: 10.1111/dme.14581.
    PubMed     Abstract available

  211. HARRISON A, Zaremba N, Brown J, Allan J, et al
    A cognitive behavioural model of the bidirectional relationship between disordered eating and diabetes self-care in people with type 1 diabetes mellitus.
    Diabet Med. 2021 Apr 2:e14578. doi: 10.1111/dme.14578.
    PubMed     Abstract available

  212. ADDALA A, Suttiratana SC, Wong JJ, Lanning MS, et al
    Cost considerations for adoption of diabetes technology are pervasive: a qualitative study of persons living with type 1 diabetes and their families.
    Diabet Med. 2021 Apr 1:e14575. doi: 10.1111/dme.14575.
    PubMed     Abstract available

  213. MURPHY HR
    2020 NICE guideline update: Good news for pregnant women with type 1 diabetes and past or current gestational diabetes.
    Diabet Med. 2021 Apr 1:e14576. doi: 10.1111/dme.14576.
    PubMed     Abstract available

    March 2021
  214. REID L, Baxter F, Forbes S
    Effects of Islet Transplantation on Microvascular and Macrovascular Complications in Type 1 Diabetes.
    Diabet Med. 2021 Mar 29:e14570. doi: 10.1111/dme.14570.
    PubMed     Abstract available

  215. SILVESTRI F, Mastrangelo M, Costantino F, Masini M, et al
    Contemporary Onset Of Atypical Chronic Inflammatory Demyelinating Polyradiculoneuropathy And Type 1 Diabetes In An Adolescent.
    Diabet Med. 2021 Mar 27:e14563. doi: 10.1111/dme.14563.
    PubMed     Abstract available

  216. SCHOFIELD H, Haycocks S, Robinson A, Edmonds M, et al
    Mortality in 98 Type 1 Diabetes Mellitus and Type 2 Diabetes Mellitus: Foot Ulcer Location is an Independent Risk Determinant.
    Diabet Med. 2021 Mar 27:e14568. doi: 10.1111/dme.14568.
    PubMed     Abstract available

  217. COOLEN M, Aalders J, Broadley M, Aanstoot HJ, et al
    Hypoglycaemia and diabetes-specific quality of life in adolescents with type 1 diabetes.
    Diabet Med. 2021 Mar 27:e14565. doi: 10.1111/dme.14565.
    PubMed     Abstract available

  218. SNAITH JR, Samocha-Bonet D, Evans J, Liu Z, et al
    Insulin Resistance in Type 1 Diabetes Managed with Metformin (INTIMET): study protocol of a double-blind placebo-controlled, randomised trial.
    Diabet Med. 2021 Mar 27:e14564. doi: 10.1111/dme.14564.
    PubMed     Abstract available

  219. TANENBAUM ML, Zaharieva DP, Addala A, Ngo J, et al
    "I was ready for it at the beginning": Parent experiences with early introduction of continuous glucose monitoring following their child's Type 1 diabetes diagnosis.
    Diabet Med. 2021 Mar 27:e14567. doi: 10.1111/dme.14567.
    PubMed     Abstract available

  220. OLIVER N
    A complex archetype.
    Diabet Med. 2021;38:e14533.

  221. O'NEILL S
    Update on technologies, medicines and treatments.
    Diabet Med. 2021;38:e14516.

  222. IBFELT EH, Vistisen D, Falberg Ronn P, Porksen S, et al
    Association between glycaemic outcome and BMI in Danish children with type 1 diabetes in 2000-2018: a nationwide population-based study.
    Diabet Med. 2021;38:e14401.
    PubMed     Abstract available

  223. HANNA KM, Kupzyk KA, Hansen JR, Jones-Ryan ML, et al
    Association of habits, triggers, glycaemic control, routines, stress and impulse control among emerging adults with type 1 diabetes.
    Diabet Med. 2021;38:e14370.
    PubMed     Abstract available

    February 2021
  224. STANTON-FAY SH, Hamilton K, Chadwick PM, Lorencatto F, et al
    The DAFNEplus programme for sustained type 1 diabetes self-management: Intervention development using the Behaviour Change Wheel.
    Diabet Med. 2021 Feb 22:e14548. doi: 10.1111/dme.14548.
    PubMed     Abstract available

  225. MILLER RG, Orchard TJ, Onengut-Gumuscu S, Chen WM, et al
    Heterogeneous Long-Term Trajectories of Glycaemic Control in Type 1 Diabetes.
    Diabet Med. 2021 Feb 19:e14545. doi: 10.1111/dme.14545.
    PubMed     Abstract available

  226. MEBRAHTU G, Maniam J, James S, Ogle GD, et al
    High incidence of type 1 diabetes in adolescents and young adults in Eritrea.
    Diabet Med. 2021 Feb 15:e14544. doi: 10.1111/dme.14544.
    PubMed     Abstract available

  227. SAUNDERS I, Bain SC
    A woman with poorly controlled type 1 diabetes and pruritic papules on her buttocks.
    Diabet Med. 2021 Feb 10:e14539. doi: 10.1111/dme.14539.
    PubMed     Abstract available

  228. STRACHAN M, Foteinopoulou E
    Response to Comment on "Impact of Routine Clinic Measurement of Random Serum C-peptide in People with a Clinician Diagnosis of Type 1 Diabetes" doi:10.1111/dme.14449.
    Diabet Med. 2021 Feb 5:e14537. doi: 10.1111/dme.14537.
    PubMed     Abstract available

  229. HERNAR I, Graue M, Strandberg RB, Lie SS, et al
    Young adults with type 1 diabetes and their experiences with diabetes follow-up and participation in the DiaPROM pilot trial: a qualitative study.
    Diabet Med. 2021 Feb 5:e14535. doi: 10.1111/dme.14535.
    PubMed     Abstract available

  230. THOMAS RL, Cheung WY, Rafferty JM, Luzio SD, et al
    Characteristics of repeat non-attenders at Diabetes Eye Screening Wales, a national community-based diabetes related retinopathy screening service, during 2003 - 2018.
    Diabet Med. 2021 Feb 5:e14536. doi: 10.1111/dme.14536.
    PubMed     Abstract available

  231. LEELARATHNA L, Thabit H, Hovorka R, Evans M, et al
    Estimated HbA1c and glucose management indicator (GMI): are they the same?
    Diabet Med. 2021;38:e14423.

  232. BARROS BSV, Santos DC, Melo LGN, Pizarro MH, et al
    Genomic ancestry and metabolic syndrome in individuals with type 1 diabetes from an admixed population: a multicentre, cross-sectional study in Brazil.
    Diabet Med. 2021;38:e14400.
    PubMed     Abstract available

  233. LEE AS, Twigg SM, Flack JR
    Metabolic syndrome in type 1 diabetes and its association with diabetes complications.
    Diabet Med. 2021;38:e14376.
    PubMed     Abstract available

  234. ASHRAFI S, Taylor D, Tang TS
    Moving Beyond "Don't Ask, Don't Tell": Mental health needs of adults with type 1 diabetes in rural and remote regions of British Columbia (BC).
    Diabet Med. 2021 Feb 1:e14534. doi: 10.1111/dme.14534.
    PubMed     Abstract available

    January 2021
  235. HELLIWELL R, Warnes H, Kietsiriroje N, Campbell M, et al
    Body mass index, estimated glucose disposal rate and vascular complications in Type 1 Diabetes: Beyond Glycated Haemoglobin.
    Diabet Med. 2021 Jan 27:e14529. doi: 10.1111/dme.14529.
    PubMed     Abstract available

  236. LIN R, Brown F, James S, Jones J, et al
    Continuous glucose monitoring: A review of the evidence in type 1 and 2 diabetes mellitus.
    Diabet Med. 2021 Jan 26:e14528. doi: 10.1111/dme.14528.
    PubMed     Abstract available

  237. HOLMES-TRUSCOTT E, Cooke DD, Hendrieckx C, Coates EJ, et al
    A comparison of the acceptability and psychometric properties of scales assessing the impact of type 1 diabetes on quality of life - Results of 'YourSAY: Quality of Life'.
    Diabet Med. 2021 Jan 14:e14524. doi: 10.1111/dme.14524.
    PubMed     Abstract available

  238. HENDRIECKX C, Morrison M, Audehm R, Barry A, et al
    Women with type 1 diabetes and women with type 2 diabetes differ in knowledge and beliefs about contraception and pregnancy.
    Diabet Med. 2021 Jan 12:e14521. doi: 10.1111/dme.14521.
    PubMed     Abstract available

  239. SMITH TA, Smart CE, Howley PP, Lopez PE, et al
    For a high fat- high protein breakfast, preprandial administration of 125% of the insulin dose improves postprandial glycaemic excursions in people with Type 1 diabetes using multiple daily injections: a cross-over trial.
    Diabet Med. 2021 Jan 9:e14512. doi: 10.1111/dme.14512.
    PubMed     Abstract available

  240. PATEL SK, Fourlanos S, Greenfield JR
    Comment on "Impact of Routine Clinic Measurement of Random Serum C-peptide in People with a Clinician Diagnosis of Type 1 Diabetes".
    Diabet Med. 2021 Jan 8:e14513. doi: 10.1111/dme.14513.
    PubMed     Abstract available

  241. SMITH TA, Smart CE, Fuery MEJ, Howley PP, et al
    In Children and Young people with type 1 Diabetes using Pump Therapy an additional 40% of the Insulin dose for a High fat, High Protein breakfast improves postprandial glycaemic excursions: A cross- over trial.
    Diabet Med. 2021 Jan 6:e14511. doi: 10.1111/dme.14511.
    PubMed     Abstract available

  242. APPERLEY LJ, Clemente M, Sultana P, Ng SM, et al
    Social deprivation affects the practice of routinely downloading blood glucose data at home for families and children with type 1 diabetes.
    Diabet Med. 2021;38:e14403.

    December 2020
  243. GOETHALS ER, Volkening LK, Tinsley L, Laffel LM, et al
    Ready or not? Greater readiness for independent self-care predicts better self-management but not HbA1c in teens with type 1 diabetes.
    Diabet Med. 2020 Dec 29:e14507. doi: 10.1111/dme.14507.
    PubMed     Abstract available

  244. BRADY EM, Bodicoat DH, Zaccardi F, Seidu S, et al
    Effectiveness of the Transformation Model, a model of care that integrates diabetes services across primary, secondary and community care: A retrospective study.
    Diabet Med. 2020 Dec 24:e14504. doi: 10.1111/dme.14504.
    PubMed     Abstract available

  245. FORDE R, Arente L, Ausili D, De Backer K, et al
    The Impact of the COVID-19 Pandemic on People with Diabetes and Diabetes Services: A pan-European Survey of Diabetes Specialist Nurses undertaken by the Foundation of European Nurses in Diabetes survey consortium.
    Diabet Med. 2020 Dec 14:e14498. doi: 10.1111/dme.14498.
    PubMed     Abstract available

  246. ROWE CW, Watkins B, Brown K, Delbridge M, et al
    Efficacy and safety of the Pregnancy-IVI, an intravenous insulin protocol for pregnancy, following antenatal betamethasone in Type 1 and Type 2 diabetes.
    Diabet Med. 2020 Dec 4:e14489. doi: 10.1111/dme.14489.
    PubMed     Abstract available

  247. JAMES S, Pryke A, Cusumano J, Jenkins A, et al
    20-Year Outcomes of Childhood-Onset Type 1 Diabetes: the CANDID Incident Cohort Survey.
    Diabet Med. 2020 Dec 3:e14473. doi: 10.1111/dme.14473.
    PubMed     Abstract available

    November 2020
  248. BEVERLY EA, Ritholz MD, Dhanyamraju K
    The Buffering Effect of Social Support on Diabetes Distress and Depressive Symptoms in Adults with Type 1 and Type 2 Diabetes.
    Diabet Med. 2020 Nov 30:e14472. doi: 10.1111/dme.14472.
    PubMed     Abstract available

  249. KENNY E, O'Malley R, Roche K, Morrissey E, et al
    Diabetes distress instruments in adults with Type 1 diabetes: a systematic review using the COSMIN (COnsensus-based Standards for the selection of health status Measurement INstruments) checklist.
    Diabet Med. 2020 Nov 24:e14468. doi: 10.1111/dme.14468.
    PubMed     Abstract available

  250. SCHLUTER S, Freckmann G, Heinemann L, Wintergerst P, et al
    Evaluation of the SPECTRUM training programme for real-time continuous glucose monitoring: a real-world multicentre prospective study in 120 adults with type 1 diabetes.
    Diabet Med. 2020 Nov 23:e14467. doi: 10.1111/dme.14467.
    PubMed     Abstract available

  251. ALTMAN JJ, Niarra R, Balkau B, Vincent-Cassy C, et al
    The JUBILE cohort: Quality of life after more than 40 years with type 1 diabetes.
    Diabet Med. 2020 Nov 16:e14460. doi: 10.1111/dme.14460.
    PubMed     Abstract available

  252. DASHORA U, Patel DC, Gregory R, Winocour P, et al
    Association of British Clinical Diabetologists (ABCD) and Diabetes UK joint position statement and recommendations on the use of sodium-glucose cotransporter inhibitors with insulin for treatment of type 1 diabetes (Updated October 2020).
    Diabet Med. 2020 Nov 11:e14458. doi: 10.1111/dme.14458.
    PubMed     Abstract available

  253. ROTBAIN CUROVIC V, Theilade S, Winther SA, Tofte N, et al
    Visit-to-visit variability of clinical risk markers in relation to long-term complications in type 1 diabetes.
    Diabet Med. 2020 Nov 11:e14459. doi: 10.1111/dme.14459.
    PubMed     Abstract available

  254. THOMSEN NOB, Dahlin LB
    Vibrotactile Sense Five years after Carpal Tunnel Release in People with Diabetes.
    Diabet Med. 2020 Nov 10:e14453. doi: 10.1111/dme.14453.
    PubMed     Abstract available

  255. HINTON W, Nemeth B, de Lusignan S, Field B, et al
    Effect of type 1 diabetes and type 2 diabetes on the risk of venous thromboembolism.
    Diabet Med. 2020 Nov 9:e14452. doi: 10.1111/dme.14452.
    PubMed     Abstract available

  256. RAMA CHANDRAN S, Zaremba N, Harrison A, Choudhary P, et al
    Disordered eating in women with type 1 diabetes: Continuous glucose monitoring reveals the complex interactions of glycaemia, self-care behaviour and emotion.
    Diabet Med. 2020 Nov 3:e14446. doi: 10.1111/dme.14446.
    PubMed     Abstract available

  257. AUKUSO L, De Lange M, Wlitshire E, Jefferies C, et al
    Youth and non-European ethnicity are associated with increased loss of publicly funded insulin pump access in New Zealand people with type 1 diabetes.
    Diabet Med. 2020 Nov 1:e14450. doi: 10.1111/dme.14450.
    PubMed     Abstract available

  258. FOTEINOPOULOU E, Clarke CAL, Pattenden RJ, Ritchie SA, et al
    Impact of Routine Clinic Measurement of Serum C-Peptide in People with a Clinician-Diagnosis of Type 1 Diabetes.
    Diabet Med. 2020 Nov 1:e14449. doi: 10.1111/dme.14449.
    PubMed     Abstract available

    October 2020
  259. DOVER AR, Strachan MWJ, McKnight JA, Stimson RH, et al
    Socioeconomic deprivation, technology use, C-peptide, smoking and other predictors of glycaemic control in adults with type 1 diabetes.
    Diabet Med. 2020 Oct 31:e14445. doi: 10.1111/dme.14445.
    PubMed     Abstract available

  260. ERDAL B, Caferoglu Z, Hatipoglu N
    The comparison of two mealtime insulin dosing algorithms for high and low glycaemic index meals in adolescents with type 1 diabetes.
    Diabet Med. 2020 Oct 29:e14444. doi: 10.1111/dme.14444.
    PubMed     Abstract available

  261. GRAY AL, Campbell MS, Berg CA, Wiebe DJ, et al
    Qualitative Analysis of Helpful and Unhelpful Aspects of Social Relationships Among Young Adults with Type 1 Diabetes.
    Diabet Med. 2020 Oct 27:e14441. doi: 10.1111/dme.14441.
    PubMed     Abstract available

  262. LEUNG JM, Tang TS, Lim CE, Laffel LM, et al
    The 4 I's of adolescent transition in type 1 diabetes care: a qualitative study.
    Diabet Med. 2020 Oct 27:e14443. doi: 10.1111/dme.14443.
    PubMed     Abstract available

  263. JANUSZEWSKI AS, Xu D, Cho YH, Benitez-Aguirre P, et al
    Skin autofluorescence in people with type 1 diabetes and people without diabetes: an eight-decade cross-sectional study with evidence of accelerated aging and associations with complications.
    Diabet Med. 2020 Oct 20:e14432. doi: 10.1111/dme.14432.
    PubMed     Abstract available

  264. HAMILTON K, Stanton-Fay SH, Chadwick PM, Lorencatto F, et al
    Sustained type 1 diabetes self-management: Specifying the behaviours involved and their influences.
    Diabet Med. 2020 Oct 19:e14430. doi: 10.1111/dme.14430.
    PubMed     Abstract available

  265. JOHNSON E, DeJonckheere M, Oliverio A, Brown KS, et al
    A theoretical model of contraceptive decision making and behavior in diabetes: A qualitative application of the Health Belief Model.
    Diabet Med. 2020 Oct 19:e14434. doi: 10.1111/dme.14434.
    PubMed     Abstract available

  266. BROWN RE, Vienneau T, Aronson R
    Canadian Real-World Outcomes of Omnipod Initiation in People with Type 1 Diabetes (COPPER study): evidence from the LMC Diabetes Registry.
    Diabet Med. 2020 Oct 11:e14420. doi: 10.1111/dme.14420.
    PubMed     Abstract available

  267. HAUGSTVEDT A, Hernar I, Graue M, Strandberg RB, et al
    Nurses' and physicians' experiences with diabetes consultations and the use of dialogue tools in the DiaPROM pilot trial: a qualitative study.
    Diabet Med. 2020 Oct 9:e14419. doi: 10.1111/dme.14419.
    PubMed     Abstract available

    September 2020
  268. VON SENGBUSCH S, Doerdelmann J, Lemke S, Lange K, et al
    Parental expectations before and after 12-month experience with video consultations combined with regular outpatient care for children with type 1 diabetes: a qualitative study.
    Diabet Med. 2020 Sep 24:e14410. doi: 10.1111/dme.14410.
    PubMed     Abstract available

    August 2020
  269. SCHULTZ AA, Wad JL, Willaing I, Norgaard K, et al
    Achieving a useful and person-centred diabetes consultation is a shared responsibility between diabetologists and people with diabetes: a qualitative study of perspectives from people with type 1 diabetes.
    Diabet Med. 2020 Aug 15:e14382. doi: 10.1111/dme.14382.
    PubMed     Abstract available

    April 2020
  270. OLIVER N, Holt RIG
    The James Lind Alliance Research Priorities for Diabetes revisited.
    Diabet Med. 2020;37:511-512.

    March 2020
  271. DASH K, Goyder EC, Quirk H
    A qualitative synthesis of the perceived factors that affect participation in physical activity among children and adolescents with type 1 diabetes.
    Diabet Med. 2020 Mar 17. doi: 10.1111/dme.14299.
    PubMed     Abstract available

    February 2020
  272. LANDI G, Andreozzi MS, Pakenham K, Grandi S, et al
    Psychosocial adjustment of young offspring in the context of parental type 1 and type 2 diabetes: a systematic review.
    Diabet Med. 2020 Feb 11. doi: 10.1111/dme.14271.
    PubMed     Abstract available

  273. HELLER SR, Gianfrancesco C, Taylor C, Elliott J, et al
    What are the characteristics of the best type 1 diabetes patient education programmes (from diagnosis to long-term care), do they improve outcomes and what is required to make them more effective?
    Diabet Med. 2020 Feb 8. doi: 10.1111/dme.14268.
    PubMed     Abstract available

  274. WINKLEY K, Upsher R, Stahl D, Pollard D, et al
    Systematic review and meta-analysis of randomized controlled trials of psychological interventions to improve glycaemic control in children and adults with type 1 diabetes.
    Diabet Med. 2020 Feb 5. doi: 10.1111/dme.14264.
    PubMed     Abstract available

    January 2020
  275. FOKKERT M, van Dijk PR, Edens M, Diez A, et al
    Performance of continuous glucose monitoring devices during intensive exercise conditions in people with diabetes: the Mont Blanc experience.
    Diabet Med. 2020 Jan 31. doi: 10.1111/dme.14259.
    PubMed     Abstract available

  276. VAN NAME MA, Cheng P, Gal RL, Kollman C, et al
    Children and adolescents with type 1 and type 2 diabetes mellitus in the Pediatric Diabetes Consortium registries: comparing clinical characteristics and glycaemic control.
    Diabet Med. 2020 Jan 14. doi: 10.1111/dme.14233.
    PubMed     Abstract available

    December 2019
  277. MCKNIGHT JA, Ochs A, Mair C, McKnight O, et al
    The effect of DAFNE education, continuous subcutaneous insulin infusion, or both in a population with type 1 diabetes in Scotland.
    Diabet Med. 2019 Dec 23. doi: 10.1111/dme.14223.
    PubMed     Abstract available

  278. VAN DUINKERKEN E, Snoek FJ, de Wit M
    The cognitive and psychological effects of living with type 1 diabetes: a narrative review.
    Diabet Med. 2019 Dec 18. doi: 10.1111/dme.14216.
    PubMed     Abstract available

  279. GRAMMES J, Kustner E, Dapp A, Hummel M, et al
    Comparative characteristics of older people with type 1 diabetes treated with continuous subcutaneous insulin infusion or insulin injection therapy: data from the German/Austrian DPV registry.
    Diabet Med. 2019 Dec 18. doi: 10.1111/dme.14218.
    PubMed     Abstract available

  280. NEFS G, Bazelmans E, Donga E, Tack CJ, et al
    Sweet dreams or bitter nightmare: a narrative review of 25 years of research on the role of sleep in diabetes and the contributions of behavioural science.
    Diabet Med. 2019 Dec 12. doi: 10.1111/dme.14211.
    PubMed     Abstract available

  281. HENDRIECKX C, Gonder-Frederick L, Heller SR, Snoek FJ, et al
    How has psycho-behavioural research advanced our understanding of hypoglycaemia in type 1 diabetes?
    Diabet Med. 2019 Dec 8. doi: 10.1111/dme.14205.
    PubMed     Abstract available

  282. SEAQUIST ER, Blonde L, McGill JB, Heller SR, et al
    Hypoglycaemia is reduced with use of inhaled Technosphere((R)) Insulin relative to insulin aspart in type 1 diabetes mellitus.
    Diabet Med. 2019 Dec 6. doi: 10.1111/dme.14202.
    PubMed     Abstract available

  283. BROADLEY MM, Zaremba N, Andrew B, Ismail K, et al
    25 Years of psychological research investigating disordered eating in people with diabetes: what have we learnt?
    Diabet Med. 2019 Dec 3. doi: 10.1111/dme.14197.
    PubMed     Abstract available

    November 2019
  284. BOUCHER SE, Aum SH, Crocket HR, Wiltshire EJ, et al
    Exploring parental perspectives after commencement of flash glucose monitoring for type 1 diabetes in adolescents and young adults not meeting glycaemic targets: a qualitative study.
    Diabet Med. 2019 Nov 26. doi: 10.1111/dme.14188.
    PubMed     Abstract available

  285. WONG JJ, Addala A, Naranjo D, Hood KK, et al
    Monetary reinforcement for self-monitoring of blood glucose among young people with type 1 diabetes: evaluating effects on psychosocial functioning.
    Diabet Med. 2019 Nov 8. doi: 10.1111/dme.14174.
    PubMed     Abstract available

    October 2019
  286. MCCOLLUM DC, O'Grady MJ
    Diminished school-based support for the management of type 1 diabetes in adolescents compared to younger children.
    Diabet Med. 2019 Oct 26. doi: 10.1111/dme.14160.
    PubMed     Abstract available

    September 2019
  287. PASTOR A, Conn J, O'Brien CL, Teng J, et al
    Clinicians feel comfortable discussing alcohol but not illicit drug use with young adults with type 1 diabetes: a survey of clinicians.
    Diabet Med. 2019 Sep 17. doi: 10.1111/dme.14136.
    PubMed     Abstract available

  288. KORDONOURI O, Lange K, Biester T, Datz N, et al
    Determinants of glycaemic outcome in the current practice of care for young people up to 21 years old with type 1 diabetes under real-life conditions.
    Diabet Med. 2019 Sep 9. doi: 10.1111/dme.14130.
    PubMed     Abstract available

    August 2019
  289. COOPER JG, Bakke A, Dalen I, Carlsen S, et al
    Factors associated with glycaemic control in adults with Type 1 diabetes: a registry-based analysis including 7601 individuals from 34 centres in Norway.
    Diabet Med. 2019 Aug 30. doi: 10.1111/dme.14123.
    PubMed     Abstract available

  290. WISTING L, Snoek F
    Terminology matters: 'diabulimia' is insufficient to describe eating disorders in individuals with Type 1 diabetes.
    Diabet Med. 2019 Aug 16. doi: 10.1111/dme.14108.

    July 2019
  291. RAWDON C, Gallagher P, Glacken M, Swallow V, et al
    Parent and adolescent communication with healthcare professionals about Type 1 diabetes management at adolescents' outpatient clinic appointments.
    Diabet Med. 2019 Jul 11. doi: 10.1111/dme.14075.
    PubMed     Abstract available

  292. NARENDRAN P, Greenfield S, Troughton J, Doherty Y, et al
    Development of a group structured education programme to support safe exercise in people with Type 1 diabetes: the EXTOD education programme.
    Diabet Med. 2019 Jul 2. doi: 10.1111/dme.14064.
    PubMed     Abstract available

    June 2019
  293. KENOWITZ JR, Hoogendoorn CJ, Commissariat PV, Gonzalez JS, et al
    Diabetes-specific self-esteem, self-care and glycaemic control among adolescents with Type 1 diabetes.
    Diabet Med. 2019 Jun 19. doi: 10.1111/dme.14056.
    PubMed     Abstract available

    February 2019
  294. AVARI P, Reddy M, Oliver N
    Is it possible to constantly and accurately monitor blood sugar levels, in people with Type 1 diabetes, with a discrete device (non-invasive or invasive)?
    Diabet Med. 2019 Feb 25. doi: 10.1111/dme.13942.
    PubMed     Abstract available

    January 2019
  295. LIVINGSTONE R, Boyle JG, Petrie JR
    How tightly controlled do fluctuations in blood glucose levels need to be to reduce the risk of developing complications in people with Type 1 diabetes?
    Diabet Med. 2019 Jan 30. doi: 10.1111/dme.13911.
    PubMed     Abstract available

  296. GROSSOEHME DH, Smith E, Standiford D, Morwessel N, et al
    Understanding adolescent and parent acceptability and feasibility experience in a large Type 1 diabetes mellitus behavioural trial.
    Diabet Med. 2019 Jan 30. doi: 10.1111/dme.13913.
    PubMed     Abstract available

    December 2018
  297. MISRA S, Mathieu C
    Are newer insulin analogues better for people with Type 1 diabetes?
    Diabet Med. 2018 Dec 26. doi: 10.1111/dme.13891.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.